Erdal Yüzbaşıoğlu

ORCID: 0000-0003-1008-4511
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal and Optic Conditions
  • Retinal Imaging and Analysis
  • Ocular Diseases and Behçet’s Syndrome
  • Retinal and Macular Surgery
  • Intraocular Surgery and Lenses
  • Glaucoma and retinal disorders
  • Ocular Disorders and Treatments
  • Corneal Surgery and Treatments
  • Cancer and Skin Lesions
  • Ocular Surface and Contact Lens
  • Corneal surgery and disorders
  • Ocular Infections and Treatments
  • Cerebral Venous Sinus Thrombosis
  • Ophthalmology and Eye Disorders
  • Retinal Development and Disorders
  • Restraint-Related Deaths
  • Vascular Malformations Diagnosis and Treatment
  • Cerebrospinal fluid and hydrocephalus
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Head and Neck Surgical Oncology
  • Ophthalmology and Visual Impairment Studies
  • Turkish Urban and Social Issues
  • Media Discourse and Social Analysis
  • Medical Malpractice and Liability Issues

Istanbul Bilim University
2008-2023

Nightingale Hospital
2016-2022

Istanbul Eye Hospital
2016

Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi
2006-2008

Istanbul University
2008

Purpose: To evaluate and determine the effect of intravitreal bevacizumab in treatment persistent central serous chorioretinopathy.Methods: This prospective, comparative clinical study included 30 eyes patients with persistent, symptomatic chorioretinopathy 3 months' duration or more. Fifteen 15 were treated injections 2.5 mg (0.1 ml) (treatment group). same characteristics who declined an acceptable control group. The visual anatomic responses observed best-corrected acuity foveal thickness...

10.3109/02713680903428306 article EN Current Eye Research 2010-02-01

Purpose: To evaluate and report the effectiveness, visual, anatomical, clinical outcome of intravitreal bevacizumab (Avastin) injection in patients with retinitis pigmentosa (RP). Methods: Our prospective study included 13 eyes 7 (4 women 3 men) age range 25–69 years (mean 44.14 years) cystoid macular edema (CME) secondary to RP. Intravitreal at a dose 1.25 mg/0.05 ml was injected via 28-gauge needle. The response rate treatment monitored functionally by visual acuity assessment anatomically...

10.1080/02713680802710692 article EN Current Eye Research 2009-01-01

Purpose: To determine intravitreal levels of interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor (VEGF) in patients with rhegmatogenous retinal detachment (RD).Methods: Vitreous samples were collected from 22 eyes during vitrectomy procedures for RD. For controls, vitreous obtained 12 without RDs pars plana vitrectomies. Control group included four macular holes eight epiretinal membranes; none had any associated vitreoretinopathy. All immediately...

10.3109/02713681003597248 article EN Current Eye Research 2010-05-14

Purpose: To report and evaluate the anatomic, clinical, visual acuity response after intravitreal ranibizumab (IVR) injection in patients with cystoid macular edema (CME) due to retinitis pigmentosa (RP). Methods: This study included 30 eyes of RP who had persistent CME at least 6 months despite medication acetazolamide. Fifteen 15 eligible were treated 0.5 mg IVR (treatment group). same characteristics refused treatment accepted as control group. The primary outcome (morphologic...

10.1089/jop.2009.0089 article EN Journal of Ocular Pharmacology and Therapeutics 2009-12-01

A 26-year-old man with degenerative high myopia had bilateral anterior chamber phakic intraocular lens (IOL) implantation under general anesthesia. The preoperative slitlamp examination was normal. No mydriatic drops were used before, during, or after the procedure. Postoperatively, pressure (IOP) in right globe increased to 60 mm Hg. After IOP controlled, pupil became fixed and dilated. Iris fluorescein angiography obtained delayed filling of iris capillary plexus large areas no perfusion...

10.1016/j.jcrs.2005.11.016 article EN Journal of Cataract & Refractive Surgery 2006-01-01

AIM: To investigate the place of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte (PLR) in diagnosis prognosis for neovascular age-related macular degeneration (AMD). METHODS: One hundred AMD patients 100 healthy controls were included study. Blood samples obtained from venous blood, which is used routine analysis, these subjected to complete blood count. NLR was defined as neutrophil count divided by number lymphocytes, PLR platelet lymphocytes. RESULTS: No statistically...

10.18240/ijo.2017.05.16 article EN cc-by-nc-nd International Journal of Ophthalmology 2017-05-12

The posterior reversible encephalopathy syndrome (PRES), a complex of cerebral disorders including headache, seizures, visual disturbances, is associated with variety conditions in which blood pressure rises acutely. Arterial hypertension can occur systemic administration bevacizumab. A few cases injection bevazicumab-induced PRES have been reported. In this article, we first report on patient who developed following intravitreal bevazicumab.

10.1089/jop.2009.0148 article EN Journal of Ocular Pharmacology and Therapeutics 2010-06-01

The objective of this study was to investigate the effect multiple intravitreal ranibizumab (IVR) injections on retinal nerve fiber layer (RNFL) in neovascular age-related macular degeneration (nAMD).One hundred sixty-eight eyes 168 patients with nAMD who received an IVR at least 3 times were included prospective interventional case series. RNFL thickness data 80 healthy eyes, used as control group, obtained. grouped follows: 3-10 (group 1, 62 37%), 10-20 2, and ≥20 3, 44 26%). measured by...

10.1089/jop.2016.0014 article EN Journal of Ocular Pharmacology and Therapeutics 2016-11-18

To report the effects of simultaneous intravitreal and intracameral injection 1.25 mg bevacizumab (Avastin) in 15 neovascular glaucoma (NVG) cases secondary to iris and/or angle neovascularization.The study included eyes patients (seven women, eight men) with NVG central retinal vein occlusions (CRVO) or proliferative diabetic retinopathy (PDR). Eight had CRVO seven PDR prior NVG. The severity neovascularization peripheric anterior synechiae (PAS) was scored from mild (+) severe (+++). A...

10.1089/jop.2008.0088 article EN Journal of Ocular Pharmacology and Therapeutics 2009-04-06

To evaluate combination treatment with intravitreal ranibizumab injection and reduced fluence photodynamic therapy for choroidal neovascularization associated angioid streaks.This is an interventional case series of 10 previously untreated eyes patients secondary to streaks. All were treated using 25 J/cm, immediately followed by at baseline, subsequent injections performed on as-needed basis thereafter. Treatment efficacy was assessed based best-corrected visual acuity optical coherence...

10.1097/iae.0b013e318205b228 article EN Retina 2011-03-10

The aim of this study was to compare the efficacy bimatoprost 0.03% with brimonidine 0.2% in preventing intraocular pressure (IOP) elevations after neodymium:yttrium–aluminum–garnet (Nd:YAG) laser posterior capsulotomy.In prospective, randomized, double-masked study, 195 eyes consecutive patients who had YAG capsulotomy for capsule opacification were recruited. Eyes received either 1 drop (98 patients) or (97 at 1h before surgery. A masked observer measured IOP by Goldmann applanation...

10.1089/jop.2009.0146 article EN Journal of Ocular Pharmacology and Therapeutics 2010-09-28

Purpose: This study aims to evaluate the role of complement factor H (CFH) in response intravitreal ranibizumab (IVR) treatment, which is administered patients with neovascular age-related macular degeneration (nAMD).Methods: In this retrospective study, 90 nAMD patients' eyes were evaluated. IVR was injected once a month for three consecutive months, and then, followed up five years by using pro re nata method.Results: Average visual acuity (BCVA) values TT group third, fourth fifth found...

10.1080/09273948.2017.1311925 article EN Ocular Immunology and Inflammation 2017-05-04

Abstract: 
 Purpose: COVID – 19 which is still the leading health problem in world, not yet fully understood, therefore study aims to investigate posterior segment of eye patients with using optical coherence tomography (OCT).
 Materials and Methods: The present was designed prospective cross-sectional. Patients a positive test result healthy controls who were older than 18 years included study. Excluded from any systemic comorbidity ocular disease. demographic clinical data,...

10.52827/hititmedj.1124153 article EN cc-by-nc Hitit Medical Journal 2023-01-25

Retinal artery occlusions are usually the result of emboli, although non-embolic causes such as vasculitides, coagulopathies, and vasospasms resulting from migraines inflammatory conditions do occur. Bevacizumab, a humanised monoclonal antibody, is designed to bind inhibit vascular endothelial growth factor (VEGF). VEGF protein that plays critical role in tumour angiogenesis, formation new blood vessels tumour. The use bevacizumab has spread worldwide, but drug related adverse events...

10.1136/bcr.01.2009.1478 article EN BMJ Case Reports 2009-05-17

Objective: To investigate the various ocular findings associated with spina bifida. Material and Methods: This study is a retrospective which included 122 patients (56 female 66 male patients) bifida who were referred to Ophthalmology Department for ophthalmologic evaluation between 2015 2017. All had shunt replacement surgery by Neurosurgery before ophthalmic examinations. Results: Results of Hirschberg cover tests showed that 49 (40.5%) strabismus 72 (59.5%) did not have strabismus. The...

10.5336/ophthal.2018-64222 article EN Turkiye Klinikleri Journal of Ophthalmology 2019-01-01

Objective: To describe the use of amniotic membrane (AM) in reoperations to decrease scar formation and improve ductions. Design: Prospective interventional case series. Participants: Four previously operated cases with restrictive strabismus. Methods: Objective clinical findings were recorded during both pre post-operative periods. Excision adhesions tissue, repositioning extraocular muscles placement AM between muscle, sclera tenon tissue performed. Results: Orthophoria no duction deficits...

10.4172/2155-9570.1000156 article EN Journal of Clinical & Experimental Ophthalmology 2011-01-01
Coming Soon ...